Frank Löscher

Dr. Löscher is the CEO, President and co-founder of Dermaliq. Prior to joining Dermaliq, he was Chief Technology Officer of Novaliq GmbH, an ophthalmic drug development company. There he was instrumental in the development of several drug candidates and products such as NOV03, CyclASol, EvoTears/NovaTears. He is inventor and co-inventor of numerous drug candidates and developed the pipeline and business case for Dermaliq. Dr. Löscher graduated as a chemist from the University of Heidelberg and received his Dr. rer. nat. degree from the University of Regensburg.